Press release
Emerging Sub-Segments Transforming the Attention Deficit Hyperactivity Disorder Market Landscape
Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder Market Size and Growth Forecast
The ADHD market is projected to experience robust expansion, reaching a valuation of $22.42 billion by 2029. This growth corresponds to a compound annual growth rate (CAGR) of 6.6% during the forecast period. Several factors are propelling this upward trajectory, including a rising number of pediatric and adult patients receiving treatment, advancements in healthcare infrastructure, increasing adoption of personalized medicine, greater societal acceptance of mental health conditions, and the rising consumption of additives and preservatives in children's diets. Key market trends also focus on technological improvements and innovative treatment methods, evolving diagnostic capabilities, the introduction of new therapeutic agents, a shift toward non-stimulant medications, and enhanced pharmaceutical therapies.
Download a free sample of the attention deficit hyperactivity disorder market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21108&type=smp
Primary Drivers Supporting Expansion in the ADHD Market
One significant element fueling growth is the expanding patient base, which encompasses both children and adults seeking effective ADHD management. With improved healthcare systems and better access to treatment, more individuals are being diagnosed and treated than ever before.
Another important driver is the increased acceptance of mental health issues in society. This has led to reduced stigma, encouraging more people to seek help and adhere to prescribed therapies. Additionally, the use of various additives and preservatives in children's diets is raising concerns, prompting greater attention to ADHD diagnosis and treatment.
View the full attention deficit hyperactivity disorder market report:
https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-global-market-report
Top Companies Steering the ADHD Market Forward
The ADHD market landscape features a number of prominent pharmaceutical companies, including Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, and Adlon Therapeutics L.P.
A notable recent development occurred in September 2024, when Collegium Pharmaceutical Inc., a specialty pharmaceutical company based in the US, acquired Ironshore Therapeutics Inc. for $525 million. This move aims to broaden Collegium's portfolio beyond pain management and strengthen its position in the expanding ADHD market with the distinctive product Jornay PM. Ironshore Therapeutics Inc. specializes in developing and commercializing ADHD therapies.
Emerging Trends Shaping Treatment Approaches in the ADHD Market
Leading companies are concentrating on the creation of innovative medications designed to enhance treatment outcomes. One notable trend is the development of extended-release tablets, which offer improved symptom control and better patient adherence by providing medication gradually throughout the day. Such formulations reduce the need for multiple daily doses, making treatment more convenient.
For example, in February 2022, the Canada-based JAMP Pharma Group introduced Guanfacine XR, a generic version of Takeda Canada Inc.'s branded INTUNIV XR. This long-acting medication works by targeting specific brain receptors to improve attention, impulse control, and hyperactivity in ADHD patients. It comes in various strengths-1 mg, 2 mg, 3 mg, and 4 mg-and is offered in 100-count bottles, allowing flexibility in treatment options.
Segment Breakdown and Comparative Analysis of the ADHD Market
This report categorizes the ADHD market into several key segments, including:
1) By Type: Stimulants and Non-Stimulants
2) By Age Group: Children and Adults
3) By Gender: Male and Female
4) By Dosage Form: Tablets, Capsules, and Other dosage forms
5) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy
Further subsegment details include:
- Stimulants: Methylphenidate-based medications, Amphetamine-based medications, Mixed Amphetamine Salts, and Dexmethylphenidate
- Non-Stimulants: Atomoxetine (Strattera), Guanfacine (Intuniv), Clonidine (Kapvay), and Bupropion (Wellbutrin)
This segmentation offers a comprehensive view of the market's structure, enabling stakeholders to identify key areas of growth and investment opportunities.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Sub-Segments Transforming the Attention Deficit Hyperactivity Disorder Market Landscape here
News-ID: 4328164 • Views: …
More Releases from The Business Research Company
Global Factors Influencing the Rapid Evolution of the Ventral Hernia Treatment M …
An overview of the ventral hernia treatment market reveals promising growth potential driven by several healthcare advancements and increasing patient demand. This sector is evolving rapidly as new technologies and strategic partnerships reshape the landscape, offering improved surgical solutions and better patient outcomes.
Ventral Hernia Treatment Market Size and Growth Projections
The ventral hernia treatment market is anticipated to experience significant expansion, reaching a valuation of $6.84 billion by 2029. This…
Leading Companies Advancing Innovation and Growth in the AI for Emergency Room a …
The adoption of artificial intelligence (AI) in emergency room and hospital management is rapidly transforming healthcare operations. With growing technological advancements and a shift in healthcare delivery models, this market is set for remarkable expansion. Let's explore the current size, key players, emerging trends, and market segmentation shaping this dynamic industry.
Projected Expansion of the AI in Emergency Room and Hospital Management Market
The AI in emergency room and hospital management…
Emerging Growth Patterns Driving Expansion in the Prescription to Over-The-Count …
The prescription to over-the-counter (Rx-to-OTC) switches market is on track for notable expansion in the coming years. As more consumers seek convenient access to medications and self-care solutions, this sector is evolving rapidly. Understanding the current market size, driving factors, key players, and emerging trends provides valuable insight into its promising future.
Anticipated Growth and Market Size of the Prescription To Over-The-Counter (Rx-to-OTC) Switches Market
The prescription to over-the-counter switches market…
Keytruda Market Perspective: Major Segments, Strategic Developments, and Leading …
The Keytruda market is poised for significant expansion in the coming years, driven by advances in cancer treatment and growing healthcare needs worldwide. As demand for more precise and effective therapies rises, Keytruda is positioned to maintain its prominence within the oncology sector. Here is an in-depth look at the market size, leading players, emerging trends, and detailed segmentation shaping its future.
Projected Growth Trajectory and Market Size of the Keytruda…
More Releases for ADHD
Ezra Dewolfe Is the Go-To Expert at The ADHD Tools for Business Owners Held Back …
Image: https://www.globalnewslines.com/uploads/2025/10/797b50a8cfa02ca6e137f2168b3acf19.jpg
For entrepreneurs with ADHD, success often feels like a constant uphill battle. They are innovative, driven, and capable of building remarkable businesses, yet behind the scenes they are weighed down by missed deadlines, inconsistent execution, and burnout. Many blame themselves, thinking they simply lack discipline. In reality, the issue is not their character but the systems they have been taught to follow.
This is why so many entrepreneurs now turn…
My ADHD Life Journal by Meryl Bengtsson Offers a Fresh, Reflective Tool for ADHD …
Image: https://www.globalnewslines.com/uploads/2025/05/1748624322.jpg
In a world that often pushes individuals with ADHD to "try harder" or "focus more," author and ADHD life coach Meryl Bengtsson invites you to try something radically different. With her book and courses, she encourages you to listen to yourself. Her new book, My ADHD Life Journal: Building Self-Awareness [https://www.amazon.co.uk/My-ADHD-Life-Journal-Self-Awareness/dp/1967679673/], is a deeply personal and practical resource designed to guide individuals on a journey of gentle reflection and…
Rising Prevalence Of ADHD Spurs Growth In The Attention-Deficit Hyperactivity Di …
The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
The market size for therapeutics related to attention deficit hyperactivity disorder (ADHD) has seen significant growth in…
ADHD Awareness Month: Dance Academy Founder Shares How Dance Helps Manage ADHD
This ADHD Awareness Month, Nix Academy - an up and coming dance and performing arts school - is highlighting the powerful impact of dance on managing ADHD symptoms. Founded by Nicky Rowe, who herself has ADHD, the academy has become a beacon of inclusivity, with around 40% of its students identifying as neurodiverse.
"Dance has been my lifeline in managing ADHD," says Nicky Rowe, Founder and Principal Teacher at Nix Academy.…
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s…
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino.
Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons.
But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter…
